\
&
Contact us
\
&
Contact us
This was 1 year ago
Locationhybrid
The Romanian Executive Agency for Higher Education, Research, Development and Innovation Funding (UEFISCDI) and the support project RO-NCP_WIDERA.NET of the Romanian NCPs, organize the workshop European Research Area Dialogue on Research Management and Administration (RMA).
The workshop fosters an European Research Area Dialogue focused on Research Management and Administration (RMA). This comprehensive workshop will feature insightful discussions, expert panels, and practical sessions aimed at shaping the future of research management.
Registration for in person or online participation is mandatory by 26 July via this form. In person participation is limited to maximum 20 attendees. The full agenda can be found in the announcement on the UEFISCDI website. Any questions, also requests for registration after 26/7, can be directed to dr. Daniela Dragomir dana.dragomir@uefiscdi.ro.
Agenda in brief (CET+1)
10.00 -10.30 Registration and Welcome coffee
10.30-10.45 Opening remarks (UEFISCDI, MCID)
10.45-12.30 Session 1: A new ERA for Research Management - Are we ready? & Session 2: Research Management Roadmap Pilot Project – State of the play
12.30-13.00 Lunch Break
13.00-14.00 NCP WIDERA. NET: Study visits for Romanian RMAs – Lessons learnt
14.00-15.00 Practical tips and tricks for designing and management successful Horizon Europe project proposals
15.00-16.30 Institutional Challenges in RMA in Romania – What we should do?
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
